Back
Oncternal Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
ONCT
Sponsored
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market
Sell
3
ONCT
Oncternal Therapeutics
Last Price:
1.70
Seasonality Move:
5.35%
7 Day Trial
ALL ACCESS PASS
$
7
How this hedge fund manager trades weekly options
Claim your free training on trading weekly optionsOncternal Therapeutics Price Quote
$1.70
+0.01 (+0.59%)
(Updated: September 19, 2024 at 3:50 PM ET)
Oncternal Therapeutics Key Stats
Sell
3
Oncternal Therapeutics (ONCT)
is a Sell
Day range:
$1.48 - $1.80
52-week range:
$1.32 - $13.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0.32%
Volume:
168.6K
Avg. volume:
57.6K
1-year change:
-74.69%
Market cap:
$5M
Revenue:
$0
EPS:
$-12.15
How Much Does Oncternal Therapeutics Make?
Data Unavailable
Is Oncternal Therapeutics Growing As A Company?
Data Unavailable
Oncternal Therapeutics Stock Price Performance
-
Did Oncternal Therapeutics Stock Go Up Last Month?
Oncternal Therapeutics share price went down by -54.45% last month -
Did ONCT's Share Price Rise Over The Last Year?
ONCT share price fell by -74.69% over the past 1 year
What Is Oncternal Therapeutics 52-Week High & Low?
-
What Is Oncternal Therapeutics’s 52-Week High Share Price?
Oncternal Therapeutics has traded as high as $13.14 over the past 52 weeks -
What Is Oncternal Therapeutics’s 52-Week Low Share Price?
Oncternal Therapeutics has traded as low as $1.32 over the past 52 weeks
Oncternal Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Oncternal Therapeutics?
-
How Much Debt Does Oncternal Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Oncternal Therapeutics Have?
Cash and short term investments quarterly total is $21.4M -
What Is Oncternal Therapeutics’s Book Value Per Share?
Book value per share is 5.32
Is Oncternal Therapeutics Cash Flow Positive?
-
What Is ONCT Cash Flow From Operations?
Cash flow from operations (TTM) is -$25.2M -
What Is Oncternal Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$137K -
What Is Oncternal Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $15.9M
Oncternal Therapeutics Return On Invested Capital
Data Unavailable
Oncternal Therapeutics Earnings Date & Stock Price
-
What Is Oncternal Therapeutics's Stock Price Today?
A single share of ONCT can be purchased today for 1.69 -
What Is Oncternal Therapeutics’s Stock Symbol?
Oncternal Therapeutics trades on the nasdaq under the ticker symbol: ONCT -
When Is Oncternal Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Oncternal Therapeutics is scheduled on November 8, 2024 -
When Is ONCT's next ex-dividend date?
Oncternal Therapeutics's next ex-dividend date is September 19, 2024 -
How To Buy Oncternal Therapeutics Stock?
You can buy Oncternal Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Oncternal Therapeutics Competitors
-
Who Are Oncternal Therapeutics's Competitors?
Below is a list of companies who compete with Oncternal Therapeutics or are related in some way:
Oncternal Therapeutics Dividend Yield
-
What Is ONCT Dividend Yield?
Oncternal Therapeutics’s dividend yield currently is 0% -
What Is Oncternal Therapeutics’s Payout Ratio?
Oncternal Therapeutics’s payout ratio is 0% -
When Did Oncternal Therapeutics Last Pay A Dividend?
The latest dividend pay date is September 19, 2024 -
What Is Oncternal Therapeutics’s Dividend Per Share?
Oncternal Therapeutics pays a dividend of $0.00 per share
Oncternal Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 4.73% |
Revenue: | 0% | 405.91% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 10.00 |
Upside from Last Price: | 491.72% |